You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-cell Chronic Lymphocytic Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

Recruiting
  • Hypogammaglobulinemia
  • +2 more
  • Columbus, Ohio
  • +1 more
Jan 16, 2023

B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)

Suspended
  • B-cell Chronic Lymphocytic Leukemia
  • Alemtuzumab
  • Peking, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2022

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New

Recruiting
  • Mantle-cell Lymphoma
  • B Cell Chronic Lymphocytic Leukemia
    • Monza, MB, Italy
      Andrea Aroldi
    May 24, 2023

    Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 10, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma, Relapsed
    • +8 more
    • PBCAR20A
    • +2 more
    • Duarte, California
    • +4 more
    Jan 4, 2023

    Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Loncastuximab Tesirine
    • (no location specified)
    Jul 24, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Jul 19, 2023

    Chronic Lymphocytic Leukemia Patients

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
      • San Francisco, California
        Power Life Sciences
      Jun 2, 2023

      Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • +5 more
      • (no location specified)
      Jul 21, 2023

      Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

      Recruiting
      • Non-hodgkin Lymphoma
      • +2 more
      • CC312
      • Tianjin, Tianjin, China
        InstituteHBDH
      Sep 12, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • (no location specified)
      Nov 22, 2023

      Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

      Completed
      • Multiple Myeloma
      • Chronic Lymphocytic Leukemia
      • Myeloma Coach or CLL Coach Mobile App
      • Springboard Beyond Cancer informational website
      • Durham, North Carolina
        Duke University
      Jun 23, 2023

      Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

      Not yet recruiting
      • Relapsed Non-Hodgkin Lymphoma
      • +6 more
      • (no location specified)
      Apr 12, 2023

      Biomarker for Infection Risk in CLL and MM

      Not yet recruiting
      • Multiple Myeloma
      • Chronic Lymphocytic Leukemia
      • Screening
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      May 3, 2023

      B-cell Non Hodgkin Lymphoma, B-cell Chronic Lymphocytic Leukemia Trial in Milwaukee (Dose Level -1: 0.75x10^6 cells/kg

      Recruiting
      • B-cell Non Hodgkin Lymphoma
      • B-cell Chronic Lymphocytic Leukemia
      • Dose Level -1: 0.75x10^6 cells/kg CAR20.19.22 cells
      • +3 more
      • Milwaukee, Wisconsin
        Medical College of Wisconsin and Froedtert Hospital
      Jul 1, 2022

      B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • Cyclophosphamide injection
      • +2 more
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Jan 18, 2023

      Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • (no location specified)
      Jul 10, 2023

      Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

      Recruiting
      • CLL/SLL
      • Jinan, Shandong, China
        Department of Hematology, Shandong Provincial Hospital Affiliate
      Jun 16, 2023

      CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

      Not yet recruiting
      • CLL
      • (no location specified)
      Oct 3, 2023

      Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

      Not yet recruiting
      • Relapsed/Refractory Chronic Lymphocytic Leukemia
      • Tianjin, Tianjin, China
        Institute of Hematology and Blood Diseases Hospital, Chinese Aca
      Jul 13, 2023

      B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
        • Manhasset, New York
          Feinstein Institute for Medical Research
        Jul 6, 2022

        CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

        Recruiting
        • CLL
        • +9 more
        • TG-1801
        • Ublituximab
        • Fayetteville, Arkansas
        • +4 more
        Jan 20, 2023

        Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

        Recruiting
        • Chronic Lymphocytic Leukemia
        • +4 more
        • Tampa, Florida
          Moffitt Cancer Center
        Jan 12, 2023

        Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)

        Not yet recruiting
        • Lymphoproliferative Disorders
        • +3 more
        • No intervention
        • (no location specified)
        Jan 30, 2023